title: Flutamide-induced photoleukomelanoderma.
authors.affiliation: Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Japan.
authors.forename: Ayaka
authors.initials: A
authors.lastname: Higashiyama
authors.affiliation: Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Japan.
authors.forename: Tomoya
authors.initials: T
authors.lastname: Yokoyama
authors.affiliation: Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Japan.
authors.forename: Yoichi
authors.initials: Y
authors.lastname: Omoto
authors.affiliation: Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Japan.
authors.forename: Koji
authors.initials: K
authors.lastname: Habe
authors.affiliation: Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Japan.
authors.forename: Keiichi
authors.initials: K
authors.lastname: Yamanaka
authors.affiliation: Department of Dermatology, Mie University, Graduate School of Medicine, Tsu, Japan.
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Mizutani
mesh_terms: D000279:Administration, Cutaneous; D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D001706:Biopsy; D001713:Biphenyl Compounds / Q000627:therapeutic use; D017298:Bisoprolol / Q000627:therapeutic use; D000077144:Clopidogrel; D003875:Drug Eruptions / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D015118:Eicosapentaenoic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D000069438:Ezetimibe / Q000627:therapeutic use; D005485:Flutamide / Q000009:adverse effects* / Q000627:therapeutic use; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010328:Patch Tests; D010787:Photosensitivity Disorders / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D012880:Skin Pigmentation / Q000187:drug effects / Q000528:radiation effects; D013472:Sunlight / Q000009:adverse effects*; D013777:Tetrazoles / Q000627:therapeutic use; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use; D028761:Withholding Treatment
chemical_list: D000726:Androgen Antagonists; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D005938:Glucocorticoids; D013777:Tetrazoles; C035276:eicosapentaenoic acid ethyl ester; D014580:Ursodeoxycholic Acid; D005485:Flutamide; D000077144:Clopidogrel; D015118:Eicosapentaenoic Acid; D000069438:Ezetimibe; D013988:Ticlopidine; C077793:candesartan cilexetil; D017298:Bisoprolol